News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,931 Results
Type
Article (9702)
Company Profile (22)
Press Release (173207)
Section
Business (71175)
Career Advice (330)
Deals (11425)
Drug Delivery (29)
Drug Development (23145)
Employer Resources (40)
FDA (3981)
Job Trends (4122)
News (107349)
Policy (7444)
Tag
Academia (609)
Alliances (11718)
Alzheimer's disease (383)
Approvals (3985)
Artificial intelligence (66)
Bankruptcy (116)
Best Places to Work (3336)
Breast cancer (47)
Cancer (547)
Career advice (288)
CAR-T (38)
Cell therapy (127)
Clinical research (18923)
Collaboration (175)
Compensation (75)
COVID-19 (792)
C-suite (47)
Data (564)
Diabetes (56)
Diagnostics (1654)
Earnings (40976)
Employer resources (37)
Events (20396)
Executive appointments (181)
FDA (4237)
Funding (350)
Gene editing (38)
Gene therapy (74)
GLP-1 (229)
Government (807)
Healthcare (5029)
Infectious disease (824)
Interviews (46)
IPO (6181)
Job creations (927)
Job search strategy (254)
Layoffs (159)
Legal (1497)
Lung cancer (110)
Lymphoma (45)
Manufacturing (63)
Medical device (3714)
Medtech (3717)
Mergers & acquisitions (5368)
Metabolic disorders (179)
Neuroscience (504)
NextGen: Class of 2025 (1918)
Non-profit (829)
Northern California (732)
Obesity (102)
Opinion (80)
People (14683)
Phase I (5731)
Phase II (8445)
Phase III (6745)
Pipeline (430)
Postmarket research (517)
Preclinical (2041)
Radiopharmaceuticals (39)
Rare diseases (104)
Real estate (1345)
Regulatory (5604)
Research institute (494)
Resumes & cover letters (43)
Series A (88)
Series B (59)
Southern California (611)
Startups (2368)
United States (5562)
Vaccines (226)
Weight loss (69)
Date
Today (2)
Last 7 days (151)
Last 30 days (654)
Last 365 days (10820)
2025 (1242)
2024 (11112)
2023 (12709)
2022 (16523)
2021 (16925)
2020 (15530)
2019 (12772)
2018 (9843)
2017 (9367)
2016 (8065)
2015 (9418)
2014 (6917)
2013 (5385)
2012 (5801)
2011 (6371)
2010 (6134)
Location
Africa (184)
Asia (11931)
Australia (1270)
California (1582)
Canada (681)
China (115)
Colorado (70)
Connecticut (70)
Europe (22533)
Florida (193)
Georgia (51)
Illinois (123)
Indiana (66)
Japan (66)
Maryland (250)
Massachusetts (1065)
Michigan (72)
Minnesota (75)
New Jersey (500)
New York (431)
North Carolina (200)
Northern California (732)
Ohio (57)
Pennsylvania (298)
South America (270)
Southern California (611)
Texas (193)
Utah (40)
Washington State (101)
182,931 Results for "third rock ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Third Rock Ventures Expands Senior Team with Seasoned Biotech Executives
Third Rock Ventures announced today that it has expanded its senior team with the addition and promotion of several industry leaders.
January 25, 2024
·
5 min read
Press Releases
Burning Rock Reports Third Quarter 2024 Financial Results
December 4, 2024
·
17 min read
Press Releases
Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
November 12, 2024
·
15 min read
Neurodegenerative disease
Scholar Rock’s Shares Soar 300% After Phase III Win in Spinal Muscular Atrophy
With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
November 4, 2024
·
2 min read
Press Releases
Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 21, 2025
·
9 min read
Press Releases
Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition
January 29, 2025
·
8 min read
Press Releases
Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)
January 29, 2025
·
9 min read
Press Releases
Burning Rock Announces Results of 2024 Annual General Meeting
December 31, 2024
·
1 min read
Business
Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress
Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today reported financial results and corporate updates for the third quarter ended September 30, 2023.
November 7, 2023
·
15 min read
1 of 18,294
Next
